Keon Wook Kang

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Topics

Tyrosine Kinase

Top Venues

Archives of pharmacal research

Journal for immunotherapy of cancer

Oxidative medicine and cellular longevity

Toxicological research

This page only lists publications with an associated author ORCID identifier.

Publications

Min Chang Choi, Sang Kyum Kim, Young Jae Choi, Yong June Choi, Suntae Kim, Kyung Hwan Jegal, Sung Chul Lim, Keon Wook Kang
Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells. Archives of pharmacal research (2023)
Miso Park, Da-Sol Kuen, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Yeonseok Chung, Sung Yun Cho, Keon Wook Kang
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. Journal for immunotherapy of cancer 11 (1) (2023)
Miso Park, Da-Sol Kuen, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Yeonseok Chung, Sung Yun Cho, Keon Wook Kang
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. Journal for immunotherapy of cancer 11 (1) (2023)
Hyun Young Kim, Undarmaa Otgontenger, Jun-Woo Kim, Young Joo Lee, Sang-Bum Kim, Sung Chul Lim, Young-Mi Kim, Keon Wook Kang
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin. Archives of pharmacal research 46 (3) (2023)
Miso Park, Da-Sol Kuen, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Yeonseok Chung, Sung Yun Cho, Keon Wook Kang
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. Journal for immunotherapy of cancer 11 (1) (2023)
Hyun Young Kim, Undarmaa Otgontenger, Jun-Woo Kim, Young Joo Lee, Sang-Bum Kim, Sung Chul Lim, Young-Mi Kim, Keon Wook Kang
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin. Archives of pharmacal research (2023)
Hyun Young Kim, Undarmaa Otgontenger, Jun-Woo Kim, Young Joo Lee, Sang-Bum Kim, Sung Chul Lim, Young-Mi Kim, Keon Wook Kang
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin. Archives of pharmacal research (2023)
Yong Jin An, Sihyang Jo, Jin-Mo Kim, Han Sun Kim, Hyun Young Kim, Sang-Min Jeon, Dawool Han, Jong-In Yook, Keon Wook Kang, Sunghyouk Park
Lactate as a major epigenetic carbon source for histone acetylation via nuclear LDH metabolism. Experimental & molecular medicine (2023)
Miso Park, Da-Sol Kuen, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Yeonseok Chung, Sung Yun Cho, Keon Wook Kang
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. Journal for immunotherapy of cancer 11 (1) (2023)
Soo Jin Kim, Kyunghyeon Lee, Jaewoo Park, Miso Park, U Ji Kim, Se-Mi Kim, Keun Ho Ryu, Keon Wook Kang
CKD-516 potentiates the anti-cancer activity of docetaxel against epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer. Toxicological research 39 (1) (2022)
Soo Jin Kim, Kyunghyeon Lee, Jaewoo Park, Miso Park, U Ji Kim, Se-Mi Kim, Keun Ho Ryu, Keon Wook Kang
CKD-516 potentiates the anti-cancer activity of docetaxel against epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer. Toxicological research 39 (1) (2022)
Hyun Young Kim, Ga Hee Baek, Wonseok Lee, Young Joo Lee, Wan Seob Shim, Young Jae Choi, Byung-Hoon Lee, Sang Kyum Kim, Keon Wook Kang
CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine. Clinical and translational medicine 12 (5) (2022)
Hyun Young Kim, Young Jae Choi, Sang Kyum Kim, Hyun Sung Kim, Dae Won Jun, Kyungrok Yoon, Nayoun Kim, Jungwook Hwang, Young-Mi Kim, Sung Chul Lim, Keon Wook Kang
Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome. Communications biology 4 (1) (2021)
Ji Won Kim, Miso Park, Suntae Kim, Sung Chul Lim, Hyung Shik Kim, Keon Wook Kang
Anti-metastatic effect of GV1001 on prostate cancer cells; roles of GnRHR-mediated Gαs-cAMP pathway and AR-YAP1 axis. Cell & bioscience 11 (1) (2021)
Suntae Kim, Ji Hye Im, Wan Kyu Kim, Young Jae Choi, Ji-Yoon Lee, Sang Kyum Kim, Sun Jo Kim, Sung Won Kwon, Keon Wook Kang
Enhanced Sensitivity of Nonsmall Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors to Phenformin: The Roles of a Metabolic Shift to Oxidative Phosphorylation and Redox Balance. Oxidative medicine and cellular longevity 2021 (2021)
Miso Park, Keon Wook Kang
Phosphatidylserine receptor-targeting therapies for the treatment of cancer. Archives of pharmacal research 42 (7) (2019)
Hyun Young Kim, Kyeong Seok Kim, Myung Ji Kim, Hyung-Shik Kim, Kwang-Youl Lee, Keon Wook Kang
Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion. Oxidative medicine and cellular longevity 2019 (2019)
Jin Won Yang, Hyo Seon Kim, Yong-Won Choi, Young-Mi Kim, Keon Wook Kang
Therapeutic application of GPR119 ligands in metabolic disorders. Diabetes, obesity & metabolism 20 (2) (2017)